1. JohnsonJM, CastleJ, Garrett-EngeleP, KanZ, LoerchPM, et al. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141–2144.
2. WangET, SandbergR, LuoS, KhrebtukovaI, ZhangL, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470–476.
3. PanQ, ShaiO, LeeLJ, FreyBJ, BlencoweBJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature genetics 40: 1413–1415.
4. GraveleyBR, BrooksAN, CarlsonJW, DuffMO, LandolinJM, et al. (2011) The developmental transcriptome of Drosophila melanogaster. Nature 471: 473–479.
5. GabutM, Samavarchi-TehraniP, WangX, SlobodeniucV, O'HanlonD, et al. (2011) An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147: 132–146.
6. PolymenidouM, Lagier-TourenneC, HuttKR, HuelgaSC, MoranJ, et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature neuroscience 14: 459–468.
7. VenablesJP, KlinckR, KohC, Gervais-BirdJ, BramardA, et al. (2009) Cancer-associated regulation of alternative splicing. Nature structural & molecular biology 16: 670–676.
8. BarashY, CalarcoJA, GaoW, PanQ, WangX, et al. (2010) Deciphering the splicing code. Nature 465: 53–59.
9. GaildratP, KriegerS, TheryJC, KillianA, RousselinA, et al. (2010) The BRCA1 c.5434C→G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements. Journal of medical genetics 47: 398–403.
10. VenablesJP (2004) Aberrant and alternative splicing in cancer. Cancer research 64: 7647–7654.
11. LefaveCV, SquatritoM, VorlovaS, RoccoGL, BrennanCW, et al. (2011) Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. The EMBO journal 30: 4084–4097.
12. ShapiroIM, ChengAW, FlytzanisNC, BalsamoM, CondeelisJS, et al. (2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218 doi:10.1371/journal.pgen.1002218
13. Allende-VegaN, DayalS, AgarwalaU, SparksA, BourdonJC, et al. (2012) p53 is activated in response to disruption of the pre-mRNA splicing machinery. Oncogene
14. YuY, MaroneyPA, DenkerJA, ZhangXH, DybkovO, et al. (2008) Dynamic regulation of alternative splicing by silencers that modulate 5′ splice site competition. Cell 135: 1224–1236.
15. HeinzenEL, GeD, CroninKD, MaiaJM, ShiannaKV, et al. (2008) Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 6: e1000001 doi:10.1371/journal.pbio.1000001
16. YinH, LuQ, WoodM (2008) Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol Ther 16: 38–45.
17. MitrpantC, AdamsAM, MeloniPL, MuntoniF, FletcherS, et al. (2009) Rational design of antisense oligomers to induce dystrophin exon skipping. Mol Ther 17: 1418–1426.
18. van DeutekomJC, JansonAA, GinjaarIB, FrankhuizenWS, Aartsma-RusA, et al. (2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357: 2677–2686.
19. MedinaMW, KraussRM (2009) The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc Med 19: 173–177.
20. DiFeoA, FeldL, RodriguezE, WangC, BeerDG, et al. (2008) A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res 68: 965–970.
21. NarlaG, DifeoA, ReevesHL, SchaidDJ, HirshfeldJ, et al. (2005) A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 65: 1213–1222.
22. CaceresJF, KornblihttAR (2002) Alternative splicing: multiple control mechanisms and involvement in human disease. Trends in genetics : TIG 18: 186–193.
23. CartegniL, ChewSL, KrainerAR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285–298.
24. FaustinoNA, CooperTA (2003) Pre-mRNA splicing and human disease. Genes & development 17: 419–437.
25. PaganiF, BaralleFE (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nature reviews Genetics 5: 389–396.
26. Sterne-WeilerT, HowardJ, MortM, CooperDN, SanfordJR (2011) Loss of exon identity is a common mechanism of human inherited disease. Genome research 21: 1563–1571.
27. KwanT, BenovoyD, DiasC, GurdS, ProvencherC, et al. (2008) Genome-wide analysis of transcript isoform variation in humans. Nat Genet 40: 225–231.
28. PickrellJK, MarioniJC, PaiAA, DegnerJF, EngelhardtBE, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464: 768–772.
29. CirulliET, SinghA, ShiannaKV, GeD, SmithJP, et al. (2010) Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol 11: R57.
30. DuanS, HuangRS, ZhangW, BleibelWK, RoeCA, et al. (2008) Genetic architecture of transcript-level variation in humans. American journal of human genetics 82: 1101–1113.
31. HindorffLA, SethupathyP, JunkinsHA, RamosEM, MehtaJP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.
32. YeoG, HoonS, VenkateshB, BurgeCB (2004) Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc Natl Acad Sci U S A 101: 15700–15705.
33. GamazonER, ZhangW, KonkashbaevA, DuanS, KistnerEO, et al. (2010) SCAN: SNP and copy number annotation. Bioinformatics 26: 259–262.
34. BowcockAM, KruegerJG (2005) Getting under the skin: the immunogenetics of psoriasis. Nature reviews Immunology 5: 699–711.
35. Lango AllenH, EstradaK, LettreG, BerndtSI, WeedonMN, et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832–838.
36. BishopDT, DemenaisF, IlesMM, HarlandM, TaylorJC, et al. (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nature genetics 41: 920–925.
37. FlicekP, AmodeMR, BarrellD, BealK, BrentS, et al. (2011) Ensembl 2011. Nucleic acids research 39: D800–806.
38. GraveleyBR (2009) Alternative splicing: regulation without regulators. Nat Struct Mol Biol 16: 13–15.
39. BaraniakAP, ChenJR, Garcia-BlancoMA (2006) Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Molecular and cellular biology 26: 1209–1222.
40. FagnaniM, BarashY, IpJY, MisquittaC, PanQ, et al. (2007) Functional coordination of alternative splicing in the mammalian central nervous system. Genome biology 8: R108.
41. HuhGS, HynesRO (1994) Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes & development 8: 1561–1574.
42. JinY, SuzukiH, MaegawaS, EndoH, SuganoS, et al. (2003) A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. The EMBO journal 22: 905–912.
43. LimLP, SharpPA (1998) Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Molecular and cellular biology 18: 3900–3906.
44. MinovitskyS, GeeSL, SchokrpurS, DubchakI, ConboyJG (2005) The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons. Nucleic acids research 33: 714–724.
45. PonthierJL, SchluepenC, ChenW, LerschRA, GeeSL, et al. (2006) Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. The Journal of biological chemistry 281: 12468–12474.
46. UnderwoodJG, BoutzPL, DoughertyJD, StoilovP, BlackDL (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Molecular and cellular biology 25: 10005–10016.
47. ZhangW, LiuH, HanK, GrabowskiPJ (2002) Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR. RNA 8: 671–685.
48. ZhuH, HasmanRA, YoungKM, KedershaNL, LouH (2003) U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA. Molecular and cellular biology 23: 5959–5971.
49. GenettaT, MorisakiH, MorisakiT, HolmesEW (2001) A novel bipartite intronic splicing enhancer promotes the inclusion of a mini-exon in the AMP deaminase 1 gene. The Journal of biological chemistry 276: 25589–25597.
50. GuoN, KawamotoS (2000) An intronic downstream enhancer promotes 3′ splice site usage of a neural cell-specific exon. The Journal of biological chemistry 2000/08/10 ed 33641–33649.
51. LiuS, AltmanRB (2003) Large scale study of protein domain distribution in the context of alternative splicing. Nucleic acids research 31: 4828–4835.
52. LewisBP, GreenRE, BrennerSE (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proceedings of the National Academy of Sciences of the United States of America 100: 189–192.
53. AlekseyenkoAV, KimN, LeeCJ (2007) Global analysis of exon creation versus loss and the role of alternative splicing in 17 vertebrate genomes. RNA 13: 661–670.
54. SugnetCW, KentWJ, AresMJr, HausslerD (2004) Transcriptome and genome conservation of alternative splicing events in humans and mice. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing 66–77.
55. HaK, Coulombe-HuntingtonJ, MajewskiJ (2009) Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation. BMC genomics 10: 519.
56. NicaAC, PartsL, GlassD, NisbetJ, BarrettA, et al. (2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 7: e1002003 doi:10.1371/journal.pgen.1002003
57. FujitaPA, RheadB, ZweigAS, HinrichsAS, KarolchikD, et al. The UCSC Genome Browser database: update 2011. Nucleic acids research 39: D876–882.
58. KuhnRM, KarolchikD, ZweigAS, WangT, SmithKE, et al. (2009) The UCSC Genome Browser Database: update 2009. Nucleic acids research 37: D755–761.
59. BensonDA, Karsch-MizrachiI, LipmanDJ, OstellJ, WheelerDL (2004) GenBank: update. Nucleic acids research 32: D23–26.
60. HubbardT, BarkerD, BirneyE, CameronG, ChenY, et al. (2002) The Ensembl genome database project. Nucleic acids research 30: 38–41.
61. Thierry-MiegD, Thierry-MiegJ (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1 S12 11–14.
62. HsuF, KentWJ, ClawsonH, KuhnRM, DiekhansM, et al. (2006) The UCSC Known Genes. Bioinformatics 22: 1036–1046.
63. KentWJ (2002) BLAT–the BLAST-like alignment tool. Genome Res 12: 656–664.
64. ZhangW, DuanS, BleibelWK, WiselSA, HuangRS, et al. (2009) Identification of common genetic variants that account for transcript isoform variation between human populations. Human genetics 125: 81–93.
65. IncA (2006) Identifying and validating alternative splicing events. Affymetrix Technical Note
66. NicolaeDL, GamazonE, ZhangW, DuanS, DolanME, et al. (2010) Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 6: e1000888 doi:10.1371/journal.pgen.1000888
67. StoreyJD, TibshiraniR (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100: 9440–9445.
68. RoyA, KucukuralA, ZhangY (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nature protocols 5: 725–738.
69. ZhangY, SkolnickJ (2005) TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic acids research 33: 2302–2309.